Plecanatide
GC-C agonist for CIC and IBS-C treatment. Structurally related to uroguanylin with enhanced GC-C receptor selectivity, providing effective bowel regularity with minimal side effects.
Our Plecanatide API (CAS:467426-54-6) is a guanylate cyclase C (GC-C) agonist peptide, dedicated to scientific research and pharmaceutical R&D related to chronic idiopathic constipation and irritable bowel syndrome, with stable supply, global fast delivery and professional service, suitable for global foreign trade procurement needs.
| Parameter | Specification |
| CAS | 467426-54-6 |
| Molecular Formula | C₆₅H₈₃N₁₅O₂₁S₆ |
| Molecular Weight | 1681.82 g/mol |
| Category | GI Motility |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | CIC, IBS-C, functional bowel disorders, opioid-induced constipation |
| CAS | 467426-54-6 |
|---|---|
| Applications | Chronic Idiopathic Constipation, GI Motility Disorders, IBS-C |
Related products
-
Mazdutide
CAS: 2259884-03-0Applications: metabolic syndrome, Overweight treatment, Type 2 diabetes -
Setmelanotide
CAS: 920014-72-8Applications: Appetite Regulation, Genetic Obesity, MC4R Agonist, metabolic syndrome -
Tirzepatide
CAS: 2023788-19-2Applications: Advanced obesity, metabolic syndrome, Type 2 diabetes -
Cagrilintide
CAS: 1415456-99-3Applications: Amylin, Diabetes adjunct therapy, obesity management, weight management